Applied DNA Sciences, Inc. (NASDAQ: APDN) has disclosed that its initial BNB holdings are valued at over $17 million following the completion of a private investment in equity (PIPE) financing. The biotechnology firm raised approximately $27 million in gross proceeds, with potential for an additional $31 million from future warrant exercises. The PIPE transaction included $15.3 million in cash and stablecoins, alongside $11.71 million in BNB trust units, totaling 435,638 units equivalent to 10,647 BNB tokens. Additionally, Applied DNA Sciences announced the acquisition of 4,908 more BNB tokens, valued at approximately $5.3 million as of October 20, 2025. This strategic move underscores the company's growing involvement in the cryptocurrency space, leveraging both DeFi and TradFi investor support.